drugset / Trial / NCT03173859
Efficacy of Rotations Between Abiraterone Acetate and Apalutamide in mCRPC Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
A randomized phase II study comparing the sequential use of abiraterone followed after progression by apalutamide with alternating cycles of abiraterone and apalutamide
Timeline
- Start
- 2018-01
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abiraterone acetate | Small molecule | 1000 mg | Oral |
| Subject | Apalutamide | Small molecule | 240 mg | Oral |